Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oje Imoukhuede

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Stroke|March 26, 2021
Shattering the CarotidsAnkur Wadhwa, Simerpreet Bal, Oje Imoukhuede, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 4, 2014
Etiologic classification of TIA and minor stroke by A-S-C-O and causative classification system as compared to TOAST reduces the proportion of patients categorized as cause undeterminedJamsheed A Desai, Ahmad R Abuzinadah, Oje Imoukhuede, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 6, 2018
Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community HospitalNoreen Kamal, Elaine Shand, Robert Swanson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 26, 2025
Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke TreatmentMary-Lou Halabi, Jillian Stang, Bijoy K Menon, et al.
Stroke|January 4, 2024
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus TenecteplaseDiana J Kim, Nishita Singh, Luciana Catanese, et al.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Stroke|January 26, 2024
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled TrialTolulope T Sajobi, Olayinka I Arimoro, Ayoola Ademola, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Stroke|March 26, 2021
Shattering the CarotidsAnkur Wadhwa, Simerpreet Bal, Oje Imoukhuede, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 4, 2014
Etiologic classification of TIA and minor stroke by A-S-C-O and causative classification system as compared to TOAST reduces the proportion of patients categorized as cause undeterminedJamsheed A Desai, Ahmad R Abuzinadah, Oje Imoukhuede, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 6, 2018
Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community HospitalNoreen Kamal, Elaine Shand, Robert Swanson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 26, 2025
Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke TreatmentMary-Lou Halabi, Jillian Stang, Bijoy K Menon, et al.
Stroke|January 4, 2024
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus TenecteplaseDiana J Kim, Nishita Singh, Luciana Catanese, et al.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Stroke|January 26, 2024
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled TrialTolulope T Sajobi, Olayinka I Arimoro, Ayoola Ademola, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Pageof 1